JP2023538619A5 - - Google Patents

Info

Publication number
JP2023538619A5
JP2023538619A5 JP2023512228A JP2023512228A JP2023538619A5 JP 2023538619 A5 JP2023538619 A5 JP 2023538619A5 JP 2023512228 A JP2023512228 A JP 2023512228A JP 2023512228 A JP2023512228 A JP 2023512228A JP 2023538619 A5 JP2023538619 A5 JP 2023538619A5
Authority
JP
Japan
Prior art keywords
benzo
imidazole
phenyl
methylsulfonyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023512228A
Other languages
English (en)
Japanese (ja)
Other versions
JP7895929B2 (ja
JP2023538619A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/046421 external-priority patent/WO2022040260A1/en
Publication of JP2023538619A publication Critical patent/JP2023538619A/ja
Publication of JP2023538619A5 publication Critical patent/JP2023538619A5/ja
Application granted granted Critical
Publication of JP7895929B2 publication Critical patent/JP7895929B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023512228A 2020-08-19 2021-08-18 線維症の処置のためのtlr9阻害剤としての1h-ベンゾ[d]イミダゾール誘導体 Active JP7895929B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063067587P 2020-08-19 2020-08-19
US63/067,587 2020-08-19
PCT/US2021/046421 WO2022040260A1 (en) 2020-08-19 2021-08-18 1h-benzo[d]imidazole derivatives as tlr9 inhibitors for the treatment of fibrosis

Publications (3)

Publication Number Publication Date
JP2023538619A JP2023538619A (ja) 2023-09-08
JP2023538619A5 true JP2023538619A5 (cg-RX-API-DMAC7.html) 2024-08-26
JP7895929B2 JP7895929B2 (ja) 2026-07-28

Family

ID=77693625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512228A Active JP7895929B2 (ja) 2020-08-19 2021-08-18 線維症の処置のためのtlr9阻害剤としての1h-ベンゾ[d]イミダゾール誘導体

Country Status (17)

Country Link
US (1) US12492188B2 (cg-RX-API-DMAC7.html)
EP (1) EP4200292B1 (cg-RX-API-DMAC7.html)
JP (1) JP7895929B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230053645A (cg-RX-API-DMAC7.html)
CN (1) CN116075510A (cg-RX-API-DMAC7.html)
AR (1) AR123286A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021329323A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023002645A2 (cg-RX-API-DMAC7.html)
CA (1) CA3189873A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023000440A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023001668A2 (cg-RX-API-DMAC7.html)
ES (1) ES2999539T3 (cg-RX-API-DMAC7.html)
IL (1) IL300702A (cg-RX-API-DMAC7.html)
MX (1) MX2023001884A (cg-RX-API-DMAC7.html)
PE (1) PE20230843A1 (cg-RX-API-DMAC7.html)
TW (1) TW202227409A (cg-RX-API-DMAC7.html)
WO (1) WO2022040260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11807622B2 (en) 2019-01-30 2023-11-07 Insilico Medicine Ip Limited TLR 9 inhibitors
KR20240148413A (ko) * 2022-02-18 2024-10-11 브리스톨-마이어스 스큅 컴퍼니 Tlr9의 억제제로서 유용한 치환된 비시클릭 헤테로아릴 화합물
MX2024009441A (es) * 2022-02-18 2024-08-14 Bristol Myers Squibb Co Compuestos de imidazopiridinilo sustituidos utiles como inhibidores del receptor tipo toll 9 (tlr9).
CN117466863B (zh) * 2022-07-20 2026-03-24 盛睿泽华医药科技(苏州)有限公司 含芳香族取代基的苯并咪唑化合物及其制备方法和用途
WO2024102886A1 (en) * 2022-11-10 2024-05-16 Bristol-Myers Squibb Company Substituted benzimidazole compounds useful as inhibitors of tlr9
CN120152957A (zh) * 2022-11-10 2025-06-13 百时美施贵宝公司 用作tlr9抑制剂的经取代的喹诺酮
WO2024163380A1 (en) * 2023-01-31 2024-08-08 Bristol-Myers Squibb Company Substituted benzimidazole compounds useful as inhibitors of tlr9

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1742637A4 (en) * 2004-04-23 2011-06-08 Paratek Pharm Innc TRANSCRIPTION FACTOR MODULATION COMPOUNDS AND METHODS OF USE
US20060235037A1 (en) 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
GB0602178D0 (en) 2006-02-03 2006-03-15 Merck Sharp & Dohme Therapeutic treatment
JP2009532501A (ja) 2006-04-04 2009-09-10 ミリアド ジェネティクス, インコーポレイテッド 疾患および障害のための化合物
EP2340243B1 (en) 2008-10-17 2014-10-08 Boehringer Ingelheim International GmbH Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
US20130158049A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 7-azaindole inhibitors of crac
US20130158066A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
AU2013245353A1 (en) * 2012-04-06 2014-09-25 Pfizer Inc. Diacylglycerol acyltransferase 2 inhibitors
WO2013156431A1 (en) 2012-04-17 2013-10-24 Syngenta Participations Ag Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives
WO2013191113A1 (ja) 2012-06-18 2013-12-27 住友化学株式会社 縮合複素環化合物
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
US9643967B2 (en) 2013-12-13 2017-05-09 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
KR102670695B1 (ko) * 2015-09-18 2024-06-05 메르크 파텐트 게엠베하 Irak 억제제로서의 헤테로아릴 화합물 및 이의 용도
AR107032A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
CN109715617B (zh) 2016-07-30 2022-04-19 百时美施贵宝公司 作为tlr7、tlr8或tlr9抑制剂的二甲氧基苯基取代的吲哚化合物
ES2902504T3 (es) 2016-09-09 2022-03-28 Bristol Myers Squibb Co Compuestos de indol sustituidos con piridilo
US11370794B2 (en) 2016-11-11 2022-06-28 Dynavax Technologies Corporation Toll-like receptor antagonist compounds and methods of use
TW201920146A (zh) 2017-07-05 2019-06-01 瑞士商先正達合夥公司 具有含硫取代基之殺有害生物活性的雜環衍生物
CN110997670B (zh) 2017-08-04 2022-11-01 百时美施贵宝公司 [1,2,4]三唑并[4,3-a]吡啶基取代的吲哚化合物
EP3661926B1 (en) 2017-08-04 2022-02-23 Bristol-Myers Squibb Company Substituted indole compounds useful as inhibitors of tlr7/8/9
CN111448190B (zh) 2017-11-14 2023-09-26 百时美施贵宝公司 取代的吲哚化合物
US12030878B2 (en) 2017-12-15 2024-07-09 Bristol-Myers Squibb Company Substituted indole ether compounds
MX2020006168A (es) 2017-12-18 2020-08-13 Bristol Myers Squibb Co Compuestos de 4-azaindol.
EA202091474A1 (ru) 2017-12-19 2020-11-18 Бристол-Маерс Сквибб Компани Замещенные индольные соединения, применимые в качестве ингибиторов tlr
WO2019126081A1 (en) 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Amide substituted indole compounds useful as tlr inhibitors
EP3728253B1 (en) 2017-12-19 2024-03-27 Bristol-Myers Squibb Company 6-azaindole compounds
KR102730859B1 (ko) 2017-12-20 2024-11-15 브리스톨-마이어스 스큅 컴퍼니 아릴 및 헤테로아릴 치환된 인돌 화합물
EA202091530A1 (ru) 2017-12-20 2020-09-14 Бристол-Маерс Сквибб Компани Диазаиндольные соединения
JP7287967B2 (ja) 2017-12-20 2023-06-06 ブリストル-マイヤーズ スクイブ カンパニー Tlr阻害剤として有効なアミノインドール化合物
WO2019136147A1 (en) * 2018-01-03 2019-07-11 The Board Of Trustees Of The University Of Illinois Toll-like receptor signaling inhibitors
EP3833440A1 (en) 2018-08-08 2021-06-16 Bristol-Myers Squibb Company Indole and azaindole inhibitors of pad enzymes
CR20220178A (es) * 2019-10-25 2022-06-15 Gilead Sciences Inc Compuestos moduladores de glp-1r

Similar Documents

Publication Publication Date Title
IL300702A (en) 1H-BENZO[D]IMIDAZOLE derivatives as TLR9 inhibitors for the treatment of fibrosis
HRP20231253T1 (hr) Supstituirani spojevi naftiridina korisni kao aktivatori t stanica
JP6339595B2 (ja) 炎症性障害の治療のための化合物及びその医薬組成物
DK2096919T3 (en) SUBSTITUTED 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINE DERIVATIVES USED FOR TREATING HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
JP2019504821A (ja) ユビキチン特異的プロテアーゼ1阻害剤としてのプリノン
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2020527560A5 (cg-RX-API-DMAC7.html)
JP2017530960A5 (cg-RX-API-DMAC7.html)
RU2017105296A (ru) Новые соединения
JP2019529529A (ja) 細胞代謝過程の阻害剤
JP2013520407A5 (cg-RX-API-DMAC7.html)
JP2014530238A5 (cg-RX-API-DMAC7.html)
RU2019111684A (ru) Новые соединения и композиции для ингибирования fasn
AR072201A1 (es) 2-arilaminoquinazolinas para el tratamiento de enfermedades proliferativas
JP2019504821A5 (cg-RX-API-DMAC7.html)
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
RU2012139830A (ru) Производные пиразолопиперидина в качестве ингибиторов nadph - оксидазы
RU2015144386A (ru) Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы
JP2014511884A5 (cg-RX-API-DMAC7.html)
JP2016525072A (ja) 炎症性障害の治療のための新規化合物及びその医薬組成物
JP7322052B2 (ja) 新規アリールもしくはヘテロアリールトリアゾロン誘導体もしくはそれらの塩、またはそれを含む医薬組成物
JP2013519724A5 (cg-RX-API-DMAC7.html)
JP2016518344A5 (cg-RX-API-DMAC7.html)
KR102788118B1 (ko) 신규한 트리아졸론 유도체 또는 그의 염, 및 그를 포함하는 제약 조성물
JP2022526432A5 (cg-RX-API-DMAC7.html)